These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 8420302)

  • 41. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Rios MB; Shan J; Faderl S; Garcia-Manero G; Ferrajoli A; Verstovsek S; Wierda W; Keating M; Talpaz M
    Cancer; 2003 Dec; 98(12):2636-42. PubMed ID: 14669283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
    Amadori S; Picardi A; Fazi P; Testi AM; Petti MC; Montefusco E; Mandelli F
    Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of blast crisis of chronic myeloid leukemia].
    Kotlarek-Haus S
    Acta Haematol Pol; 1992; 23(2 Suppl 1):23-9. PubMed ID: 1488869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance.
    Inverardi D; Lazzarino M; Morra E; Bernasconi P; Merante S; Canevari A; Pagnucco G; Bernasconi C
    Haematologica; 1990; 75(2):146-8. PubMed ID: 2358205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic myelogenous leukemia in nonlymphoid blastic phase: analysis of the results of first salvage therapy with three different treatment approaches for 162 patients.
    Sacchi S; Kantarjian HM; O'Brien S; Cortes J; Rios MB; Giles FJ; Beran M; Koller CA; Keating MJ; Talpaz M
    Cancer; 1999 Dec; 86(12):2632-41. PubMed ID: 10594858
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of CML with blastic crisis by the combination therapy of VP and low-dose Ara-C].
    Chou T; Wakabayashi M; Hayashi N; Arakawa M
    Rinsho Ketsueki; 1992 Sep; 33(9):1263-7. PubMed ID: 1433949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Blast crisis of chronic myeloid leukemia with positive Philadelphia chromosome: course and clinico-hematologic profile in 80 patients].
    Cervantes F; Rozman M; Salgado C; Vives-Corrons JL; Montserrat E; Rozman C
    Med Clin (Barc); 1990 May; 94(18):681-4. PubMed ID: 2388491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia.
    Koller CA; Kantarjian HM; Feldman EJ; O'Brien S; Rios MB; Estey E; Keating M
    Cancer; 1999 Dec; 86(11):2246-51. PubMed ID: 10590364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients].
    Cervantes F; Sanz C; Bosch F; Rozman C
    Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of chronic granulocytic leukemia in blastic crisis.
    Canellos GP
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
    [No Abstract]   [Full Text] [Related]  

  • 53. [Extramedullary blastic crisis of chronic myelogenous leukemia--a case with various additional chromosomal appearance].
    Nakao Y; Ohta T; Koh K; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Rinsho Byori; 1994 Apr; 42(4):425-9. PubMed ID: 8176852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous meningeal and testicular lymphoblastic transformation of Ph1-positive chronic myelocytic leukaemia in a three-year-old boy.
    Carlsen NL; Erichsen G; Lisse I
    Anticancer Res; 1990; 10(6):1739-41. PubMed ID: 2285252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
    Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
    Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
    Kantarjian HM; Talpaz M; Kontoyiannis D; Gutterman J; Keating MJ; Estey EH; O'Brien S; Rios MB; Beran M; Deisseroth A
    J Clin Oncol; 1992 Mar; 10(3):398-405. PubMed ID: 1740679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic myelogenous leukemia in blastic crisis with chemotherapy incorporating vindesine-prednisolone.
    Uzuka Y; Saito Y
    Cancer Treat Rep; 1985 Nov; 69(11):1297-9. PubMed ID: 3867403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinico-hematological characteristics of acute transformation of chronic myeloproliferative syndromes].
    Hernández JM; San Miguel JF; González M; Moraleda JM; Moro MJ; Hernández J; Cuesta B; López Borrasca A
    Med Clin (Barc); 1991 Sep; 97(10):369-72. PubMed ID: 1745085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chronic myeloid leukemia].
    Gaiger A; Hinterberger W
    Wien Med Wochenschr; 1991; 141(9-10):195-8. PubMed ID: 1949841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II study of mitoxantrone and 5-azacytidine for accelerated and blast crisis of chronic myelogenous leukemia: a study of the Eastern Cooperative Oncology Group.
    Dutcher JP; Eudey L; Wiernik PH; Paietta E; Bennett JM; Arlin Z; Kellermeyer R; Rowe J; O'Connell M; Oken M
    Leukemia; 1992 Aug; 6(8):770-5. PubMed ID: 1379312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.